4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001104659-22-073083
CIK 0001508381other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:47 PM ET
Size
5.8 KB
Accession
0001104659-22-073083
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock, par value $0.001 per share
2022-03-31$9.50/sh+77,887$739,927→ 1,616,840 total(indirect: Shares held through GD Holdings and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (1)
- [F1]Effective as of March 31, 2022, an aggregate amount of $739,926 of principal and accrued interest in a convertible promissory note issued to GD Holdings converted in accordance with its terms into 77,887 shares of the Issuer's common stock.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:47 PM ET
- Size
- 5.8 KB